Aspire Pharma, a rapidly growing UK-based specialty generics business, has announced the acquisition of Charlwood Pharma, a ...

Oncolytic immunotherapies specialist Replimune Group has announced that the US Food and Drug Administration (FDA) has ...

US trade group the Research and Manufacturers of America (PhRMA) has hailed the impact of direct purchase programs (DPPs), ...

Swiss pharma giant Roche’s US subsidiary Genentech yesterday revealed that the US Food and Drug Administration (FDA) has ...

South Korea-based Samsung Bioepis and Chinese biotech start-up Phrontline Biopharma have entered into a global collaboration ...

Five months after closing its Series B financing, USA-based NewLimit has raised an additional $45 million from Eli Lilly), ...

US contract manufacturer Life Science Outsourcing has appointed Doug Constable as chief executive to steer its next growth ...

South Korea’s SK Biopharmaceuticals (KRX: 326030) has partnered with Brazil’s Eurofarma to launch Mentis Care, a ...

Summit Therapeutics (Nasdaq: SMMT) said it plans to file a biologics license application in the fourth quarter for ...

Israeli pharma major Teva (NYSE: TEVA) has entered a licensing agreement with Singapore-based Prestige Biopharma (KOSDAQ: ...

California, USA-based Alto Neuroscience saw its shares shoot up more than 80% to $11.00 yesterday, after it revealed it has ...

Following an extensive review, Belgian biotech Galapagos today revealed its intention to wind down its cell therapy business ...